Onychodystrophy PCR Testing
Targeted Treatment Starts by Identifying the Exact Infectious Organism
Laboratory testing provides objective information for precise treatment.
Causative infectious organisms are colorless and invisible to the eye.
Determining the exact infectious agents to treat leads to improved patient outcomes.
Learn more about adding PCR testing to your patient care algorithm
Complete the form below to get answers to your questions about BakoDx’s Onychodystrophy PCR testing.
Please note: individual reflex test options of certain yeasts and pseudomonas aeruginosa are pending availability in NY (see chart below).
Advantages of the BakoDx Onychodystrophy PCR Test
Determine the genus and species of the infectious organism to provide the safest, most effective oral and topical treatments
Assess patient results with high confidence
99.9% analytical specificity 86% clinical sensitivity;¹ Correlates highly with histopathology
Eliminate unnecessary additional testing, focus on the relevant agents of disease, and prevent treatment course changes
Document the genus and species information needed for pre-authorization of many anti-fungal prescriptions
Contracted with all major insurance plans, and over 200 local insurance plans; Covered by Medicare
Begin appropriate treatment quickly with 1-2 day turnaround time
The Difference with Our Proprietary Technology
- Reflexes to secondary testing only when positive to reduce medical costs
- Identifies multiple causative organism targets in a single specimen
- Detects low levels of concentration of the causative organism
- Filters out contaminants present in the collected specimen
Educational Resources for Onychodystrophy
¹BakoDx internal validation
Disclaimer: BakoDx, as a partner to your practice, provides learning resources to help you better serve your patients. The information contained within this document should be used at a physician’s discretion. BakoDx assumes no liability for its content..